Form 8-K - Current report:
SEC Accession No. 0001628280-17-001119
Filing Date
2017-02-10
Accepted
2017-02-10 17:00:55
Documents
3
Period of Report
2017-02-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - CALDOLOR PED FEVER STUDY a8k-caldolorpedfeverstudy.htm 8-K 21532
2 EXHIBIT 99.1 PRESS RELEASE - CALDOLOR PEDS FEVER STUDY pressrelease-caldolorpedsf.htm EX-99.1 14941
3 cumberlanda09.jpg GRAPHIC 96793
  Complete submission text file 0001628280-17-001119.txt   170864
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17594420
SIC: 2834 Pharmaceutical Preparations